EPOFIT 2000IU INJECTION
| Product Name | Epofit 2000 IU Injection |
| Generic Name | Epoetin Alfa |
| Dosage Form | Injection |
| Strength | 2000 IU |
| Therapeutic Category | Anti-anemic |
| Indication | Anemia in CKD & Chemotherapy |
| Packaging | Prefilled Syringe/Vial |
| Storage | Store at 2°C–8°C; do not freeze |
| Prescription | Required |
EPOFIT 2000IU INJECTION
Epofit 2000IU Injection is an erythropoietin-based medication used to treat anemia, especially in patients with chronic kidney disease (CKD), chemotherapy-induced anemia, or other medical conditions causing low hemoglobin levels. It works by stimulating the bone marrow to produce more red blood cells, helping improve oxygen supply throughout the body. Epofit 2000IU Injection is commonly prescribed under medical supervision to reduce fatigue and lower the need for blood transfusions.
This injection contains epoetin alfa, a synthetic form of human erythropoietin that supports healthy red blood cell production. Epofit 2000IU Injection is widely used in nephrology and oncology care for managing anemia related to kidney disorders or cancer treatments. Regular monitoring of hemoglobin levels ensures safe and effective therapy based on the patient’s medical needs.
Epofit 2000IU Injection is supplied following recognized quality standards to ensure safety, consistency, and reliable therapeutic performance. Proper storage and administration help maintain its potency and effectiveness. It is regarded as one of the most dependable products in the pharmaceutical sector for anemia management and supportive care therapy.
Product Features
- Contains Epoetin Alfa 2000 IU
- Used for anemia management in CKD and chemotherapy patients
- Stimulates red blood cell production
- Helps reduce the need for blood transfusions
- Administered under medical supervision
How It Helps
- Increases hemoglobin levels
- Improves oxygen delivery in the body
- Reduces fatigue and weakness
- Supports overall recovery

Reviews
There are no reviews yet.